Respiratory Stimulant News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Respiratory stimulant. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Respiratory Stimulant Today - Breaking & Trending Today

Enalare Therapeutics Announces Partnership with BARDA to Advance Development of its Lead Product ENA-001

Enalare Therapeutics Announces Partnership with BARDA to Advance Development of its Lead Product ENA-001
Posted Apr 29, 2021
The Funding Will Accelerate Development of an Intramuscular Formulation of a Novel Agnostic Respiratory Stimulant to Treat Life-threatening Respiratory Depression
PRINCETON, N.J. - Enalare Therapeutics Inc. announced today that it has received an initial contract from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, to support development of the company’s lead product ENA-001. The funding will be used to advance development of an intramuscular (IM) formulation for ENA-001, a New Chemical Entity (NCE) with a novel mechanism of action and potential broad applications as an agnostic respiratory stimulant. The funding is provided via the BARDA Division of Research, Innovation, a ....

Joe Pergolizzi , Chemical Medical Countermeasures Mcms Program , Biomedical Advanced Research , Us Department Of Health , Human Services , Enalare Therapeutics Announces Partnership , Drug Administration , Development Authority , Enalare Therapeutics Inc , Office Of The , Division Of Research , Therapeutics Announces Partnership , Lead Product , Funding Will Accelerate Development , Intramuscular Formulation , Novel Agnostic , Respiratory Stimulant , Treat Life Threatening Respiratory Depression , Assistant Secretary , New Chemical Entity , Repurposing Drugs , Chemical Threats , Medical Countermeasures , Chief Rd Officer , எங்களுக்கு துறை ஆஃப் ஆரோக்கியம் , மனிதன் சேவைகள் ,

It's Albert Hofmann's Birthday: The Father Of LSD Would Have Turned 115 Today

This article was originally published on Microdose Psychedelic Insights and appears here with permission.
Albert Hofmann, the famous Swiss scientist best known for discovering the psychedelic drug, LSD (lysergic acid diethylamide), would have turned 115 years old today. Endearingly called “The Father of LSD”, Hofmann lived to the ripe old age of 102 and his powerful legacy still lives on to this day. A powerful catalyst for the counterculture movement of the 60’s and 70’s, LSD also showed immense therapeutic potential for neuropsychiatric disorders in its early days.
Hofmann Discovered LSD in 1938 When Trying to Create a Circulatory & Respiratory Stimulant
Hofmann discovered the drug in 1938 while working for the Swiss pharmaceutical company Sandoz. His pursuit of isolating, purifying and synthesizing active compounds from medicinal plants led him to ultimately create LSD from ergot, a rye fungus. Hofmann was initially trying to create a circulatory and r ....

Albert Hofmann , Microdose Psychedelic Insights , Respiratory Stimulant , First Time , Recounts His Incredible Experience , His Book , Problem Child , Promising Medicine , Clinical Potential , True Psychedelic , ஆல்பர்ட் ஹாஃப்மேன் , முதல் நேரம் , அவரது நூல் , ப்ராப்லம் குழந்தை , ப்ராமிஸிஂக் மருந்து , மருத்துவ பொடெந்ஶியல் ,